A Non-interventional Ambispective Real-world Cohort of rEfractory and reLapsed (R/R) FLT3 Mutated Acute MyEloid Leukemia (AML) Patients Treated With Gilteritinib in FrANCE
Clinical trial NCT05193448 · COMPLETED
Trial details
- NCT number
- NCT05193448
- Sponsor
- French Innovative Leukemia Organisation
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-07-05
- Primary completion
- 2021-10-31
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.